{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:52:16Z","timestamp":1777006336311,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005006","name":"Asan Institute for Life Sciences, Asan Medical Center","doi-asserted-by":"publisher","award":["2022IF0007"],"award-info":[{"award-number":["2022IF0007"]}],"id":[{"id":"10.13039\/501100005006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1038\/s41409-024-02506-w","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T05:45:37Z","timestamp":1736919937000},"page":"447-457","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Incidence, risk factors, and outcomes of transplant-associated thrombotic microangiopathy in pediatric patients after allogeneic hematopoietic cell transplantation: a single-institution prospective study"],"prefix":"10.1038","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5817-0278","authenticated-orcid":false,"given":"Su Hyun","family":"Yoon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Han","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyery","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Seok","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8799-4068","authenticated-orcid":false,"given":"Ho Joon","family":"Im","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6376-672X","authenticated-orcid":false,"given":"Kyung-Nam","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"2506_CR1","doi-asserted-by":"publisher","first-page":"308.e301","DOI":"10.1016\/j.jtct.2020.12.010","volume":"27","author":"A Li","year":"2021","unstructured":"Li A, Bhatraju PK, Chen J, Chung DW, Hilton T, Houck K, et al. Prognostic biomarkers for thrombotic microangiopathy after acute graft-versus-host disease: a nested case-control study. Transpl Cell Ther. 2021;27:308.e301\u2013e308. https:\/\/doi.org\/10.1016\/j.jtct.2020.12.010.","journal-title":"Transpl Cell Ther"},{"key":"2506_CR2","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/01.tp.0000230373.82376.46","volume":"82","author":"C Uderzo","year":"2006","unstructured":"Uderzo C, Bonanomi S, Busca A, Renoldi M, Ferrari P, Iacobelli M, et al. Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Transplantation. 2006;82:638\u201344. https:\/\/doi.org\/10.1097\/01.tp.0000230373.82376.46.","journal-title":"Transplantation"},{"key":"2506_CR3","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.bbmt.2013.12.565","volume":"20","author":"S Jodele","year":"2014","unstructured":"Jodele S, Fukuda T, Vinks A, Mizuno K, Laskin BL, Goebel J, et al. Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Biol Blood Marrow Transplant. 2014;20:518\u201325. https:\/\/doi.org\/10.1016\/j.bbmt.2013.12.565.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2506_CR4","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","volume":"124","author":"S Jodele","year":"2014","unstructured":"Jodele S, Davies SM, Lane A, Khoury J, Dandoy C, Goebel J, et al. Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults. Blood. 2014;124:645\u201353. https:\/\/doi.org\/10.1182\/blood-2014-03-564997.","journal-title":"Blood"},{"key":"2506_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.transci.2016.04.007","volume":"54","author":"S Jodele","year":"2016","unstructured":"Jodele S, Dandoy CE, Myers KC, El-Bietar J, Nelson A, Wallace G, et al. New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Transfus Apher Sci. 2016;54:181\u201390. https:\/\/doi.org\/10.1016\/j.transci.2016.04.007.","journal-title":"Transfus Apher Sci"},{"key":"2506_CR6","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1080\/17474086.2021.1960816","volume":"14","author":"S Jodele","year":"2021","unstructured":"Jodele S, Sabulski A. Transplant-associated thrombotic microangiopathy: elucidating prevention strategies and identifying high-risk patients. Expert Rev Hematol. 2021;14:751\u201363. https:\/\/doi.org\/10.1080\/17474086.2021.1960816.","journal-title":"Expert Rev Hematol"},{"key":"2506_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","volume":"29","author":"S Jodele","year":"2015","unstructured":"Jodele S, Laskin BL, Dandoy CE, Myers KC, El-Bietar J, Davies SM, et al. A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury. Blood Rev. 2015;29:191\u2013204. https:\/\/doi.org\/10.1016\/j.blre.2014.11.001.","journal-title":"Blood Rev"},{"key":"2506_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3389\/fped.2019.00133","volume":"7","author":"CC Dvorak","year":"2019","unstructured":"Dvorak CC, Higham C, Shimano KA. Transplant-associated thrombotic microangiopathy in pediatric hematopoietic cell transplant recipients: a practical approach to diagnosis and management. Front Pediatr. 2019;7:133. https:\/\/doi.org\/10.3389\/fped.2019.00133.","journal-title":"Front Pediatr"},{"key":"2506_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jtct.2022.11.015","volume":"29","author":"ML Schoettler","year":"2023","unstructured":"Schoettler ML, Carreras E, Cho B, Dandoy CE, Ho VT, Jodele S, et al. Harmonizing definitions for diagnostic criteria and prognostic assessment of transplantation-associated thrombotic microangiopathy: a report on behalf of the european society for blood and marrow transplantation, american society for transplantation and cellular therapy, Asia-Pacific blood and marrow transplantation group, and center for international blood and marrow transplant research. Transpl Cell Ther. 2023;29:151\u201363. https:\/\/doi.org\/10.1016\/j.jtct.2022.11.015.","journal-title":"Transpl Cell Ther"},{"key":"2506_CR10","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1038\/s41409-021-01283-0","volume":"56","author":"JA Young","year":"2021","unstructured":"Young JA, Pallas CR, Knovich MA. Transplant-associated thrombotic microangiopathy: theoretical considerations and a practical approach to an unrefined diagnosis. Bone Marrow Transplant. 2021;56:1805\u201317. https:\/\/doi.org\/10.1038\/s41409-021-01283-0.","journal-title":"Bone Marrow Transplant"},{"key":"2506_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3390\/jpm11060467","volume":"11","author":"A Ramgopal","year":"2021","unstructured":"Ramgopal A, Sridar S, Dalal J, Kalpatthi R. Thrombotic microangiopathy: multi-institutional review of pediatric patients who underwent HSCT. J Pers Med. 2021;11:467. https:\/\/doi.org\/10.3390\/jpm11060467.","journal-title":"J Pers Med"},{"key":"2506_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/cc5713","volume":"11","author":"RL Mehta","year":"2007","unstructured":"Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31. https:\/\/doi.org\/10.1186\/cc5713.","journal-title":"Crit Care"},{"key":"2506_CR13","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120:c179\u201384. https:\/\/doi.org\/10.1159\/000339789.","journal-title":"Nephron Clin Pract"},{"key":"2506_CR14","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.bbmt.2017.11.021","volume":"24","author":"KN Koh","year":"2018","unstructured":"Koh KN, Sunkara A, Kang G, Sooter A, Mulrooney DA, Triplett B, et al. Acute kidney injury in pediatric patients receiving allogeneic hematopoietic cell transplantation: incidence, risk factors, and outcomes. Biol Blood Marrow Transplant. 2018;24:758\u201364. https:\/\/doi.org\/10.1016\/j.bbmt.2017.11.021.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2506_CR15","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","volume":"158","author":"PE Stevens","year":"2013","unstructured":"Stevens PE, Levin A.Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158:825\u201330. https:\/\/doi.org\/10.7326\/0003-4819-158-11-201306040-00007.","journal-title":"Ann Intern Med"},{"key":"2506_CR16","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.kint.2021.06.028","volume":"100","author":"NH Lameire","year":"2021","unstructured":"Lameire NH, Levin A, Kellum JA, Cheung M, Jadoul M, Winkelmayer WC, et al. Harmonizing acute and chronic kidney disease definition and classification: report of a kidney disease: improving global outcomes (KDIGO) consensus conference. Kidney Int. 2021;100:516\u201326. https:\/\/doi.org\/10.1016\/j.kint.2021.06.028.","journal-title":"Kidney Int"},{"key":"2506_CR17","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995;15:825\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"2506_CR18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1053\/bbmt.2003.50026","volume":"9","author":"SJ Lee","year":"2003","unstructured":"Lee SJ, Vogelsang G, Flowers ME. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003;9:215\u201333. https:\/\/doi.org\/10.1053\/bbmt.2003.50026.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2506_CR19","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.bbmt.2015.07.004","volume":"21","author":"A Akil","year":"2015","unstructured":"Akil A, Zhang Q, Mumaw CL, Raiker N, Yu J, de Mendizabal NV, et al. Biomarkers for diagnosis and prognosis of sinusoidal obstruction syndrome after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2015;21:1739\u201345. https:\/\/doi.org\/10.1016\/j.bbmt.2015.07.004.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2506_CR20","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.bbmt.2017.07.021","volume":"23","author":"RPS Bajwa","year":"2017","unstructured":"Bajwa RPS, Mahadeo KM, Taragin BH, Dvorak CC, McArthur J, Jeyapalan A, et al. Consensus report by pediatric acute lung injury and sepsis investigators and pediatric blood and marrow transplantation consortium joint working committees: supportive care guidelines for management of veno-occlusive disease in children and adolescents, Part 1: focus on investigations, prophylaxis, and specific treatment. Biol Blood Marrow Transplant 2017;23:1817\u201325. https:\/\/doi.org\/10.1016\/j.bbmt.2017.07.021.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2506_CR21","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","volume":"44","author":"RJ Jones","year":"1987","unstructured":"Jones RJ, Lee KS, Beschorner WE, Vogel VG, Grochow LB, Braine HG, et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation. 1987;44:778\u201383. https:\/\/doi.org\/10.1097\/00007890-198712000-00011.","journal-title":"Transplantation"},{"key":"2506_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/hep.1840040121","volume":"4","author":"GB McDonald","year":"1984","unstructured":"McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology. 1984;4:116\u201322. https:\/\/doi.org\/10.1002\/hep.1840040121.","journal-title":"Hepatology"},{"key":"2506_CR23","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1093\/cid\/ciy696","volume":"68","author":"RF Chemaly","year":"2019","unstructured":"Chemaly RF, Chou S, Einsele H, Griffiths P, Avery R, Razonable RR, et al. Definitions of resistant and refractory cytomegalovirus infection and disease in transplant recipients for use in clinical trials. Clin Infect Dis. 2019;68:1420\u20136. https:\/\/doi.org\/10.1093\/cid\/ciy696.","journal-title":"Clin Infect Dis"},{"key":"2506_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/cid\/ciw668","volume":"64","author":"P Ljungman","year":"2017","unstructured":"Ljungman P, Boeckh M, Hirsch HH, Josephson F, Lundgren J, Nichols G, et al. Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials. Clin Infect Dis. 2017;64:87\u201391. https:\/\/doi.org\/10.1093\/cid\/ciw668.","journal-title":"Clin Infect Dis"},{"key":"2506_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.818167","volume":"12","author":"SS Li","year":"2022","unstructured":"Li SS, Zhang N, Jia M, Su M. Association between cytomegalovirus and epstein-barr virus co-reactivation and hematopoietic stem cell transplantation. Front Cell Infect Microbiol. 2022;12:818167. https:\/\/doi.org\/10.3389\/fcimb.2022.818167.","journal-title":"Front Cell Infect Microbiol"},{"key":"2506_CR26","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"JP Donnelly","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, et al. Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis. 2020;71:1367\u201376. https:\/\/doi.org\/10.1093\/cid\/ciz1008.","journal-title":"Clin Infect Dis"},{"key":"2506_CR27","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1183\/09059180.00001011","volume":"20","author":"M Kousha","year":"2011","unstructured":"Kousha M, Tadi R, Soubani AO. Pulmonary aspergillosis: a clinical review. Eur Respir Rev. 2011;20:156\u201374. https:\/\/doi.org\/10.1183\/09059180.00001011.","journal-title":"Eur Respir Rev"},{"key":"2506_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.rmed.2018.06.029","volume":"141","author":"A Kanj","year":"2018","unstructured":"Kanj A, Abdallah N, Soubani AO. The spectrum of pulmonary aspergillosis. Respir Med. 2018;141:121\u201331. https:\/\/doi.org\/10.1016\/j.rmed.2018.06.029.","journal-title":"Respir Med"},{"key":"2506_CR29","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.jacc.2009.06.020","volume":"54","author":"YM Law","year":"2009","unstructured":"Law YM, Hoyer AW, Reller MD, Silberbach M. Accuracy of plasma B-type natriuretic peptide to diagnose significant cardiovascular disease in children: the Better Not Pout Children! Study. J Am Coll Cardiol. 2009;54:1467\u201375. https:\/\/doi.org\/10.1016\/j.jacc.2009.06.020.","journal-title":"J Am Coll Cardiol"},{"key":"2506_CR30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/sj.bmt.1702507","volume":"26","author":"JA Snowden","year":"2000","unstructured":"Snowden JA, Hill GR, Hunt P, Carnoutsos S, Spearing RL, Espiner E, et al. Assessment of cardiotoxicity during haemopoietic stem cell transplantation with plasma brain natriuretic peptide. Bone Marrow Transplant. 2000;26:309\u201313. https:\/\/doi.org\/10.1038\/sj.bmt.1702507.","journal-title":"Bone Marrow Transplant"},{"key":"2506_CR31","unstructured":"Rifai N Tietz textbook of clinical chemistry and molecular diagnostics, 6th edn Saunders: St. Louis, 2017."},{"key":"2506_CR32","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1182\/bloodadvances.2019001242","volume":"4","author":"M Schoettler","year":"2020","unstructured":"Schoettler M, Lehmann LE, Margossian S, Lee M, Kean LS, Kao PC, et al. Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort. Blood Adv. 2020;4:2536\u201347. https:\/\/doi.org\/10.1182\/bloodadvances.2019001242.","journal-title":"Blood Adv"},{"key":"2506_CR33","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","volume":"90","author":"BS Cho","year":"2010","unstructured":"Cho BS, Yahng SA, Lee SE, Eom KS, Kim YJ, Kim HJ, et al. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation. Transplantation. 2010;90:918\u201326. https:\/\/doi.org\/10.1097\/TP.0b013e3181f24e8d.","journal-title":"Transplantation"},{"key":"2506_CR34","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/bmt.2014.17","volume":"49","author":"J Labrador","year":"2014","unstructured":"Labrador J, Lopez-Corral L, Lopez-Godino O, Vazquez L, Cabrero-Calvo M, Perez-Lopez R, et al. Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus. Bone Marrow Transplant. 2014;49:684\u201390. https:\/\/doi.org\/10.1038\/bmt.2014.17.","journal-title":"Bone Marrow Transplant"},{"key":"2506_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2165\/00003495-200969020-00004","volume":"69","author":"CM Choi","year":"2009","unstructured":"Choi CM, Schmaier AH, Snell MR, Lazarus HM. Thrombotic microangiopathy in haematopoietic stem cell transplantation: diagnosis and treatment. Drugs. 2009;69:183\u201398. https:\/\/doi.org\/10.2165\/00003495-200969020-00004.","journal-title":"Drugs"},{"key":"2506_CR36","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41409-021-01551-z","volume":"57","author":"WA Bethge","year":"2022","unstructured":"Bethge WA, Eyrich M, Mielke S, Meisel R, Niederwieser D, Schlegel PG, et al. Results of a multicenter phase I\/II trial of TCRalphabeta and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patients. Bone Marrow Transplant. 2022;57:423\u201330. https:\/\/doi.org\/10.1038\/s41409-021-01551-z.","journal-title":"Bone Marrow Transplant"},{"key":"2506_CR37","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1182\/blood-2018-07-861575","volume":"132","author":"A Bertaina","year":"2018","unstructured":"Bertaina A, Zecca M, Buldini B, Sacchi N, Algeri M, Saglio F, et al. Unrelated donor vs HLA-haploidentical alpha\/beta T-cell- and B-cell-depleted HSCT in children with acute leukemia. Blood. 2018;132:2594\u2013607. https:\/\/doi.org\/10.1182\/blood-2018-07-861575.","journal-title":"Blood"},{"key":"2506_CR38","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1182\/bloodadvances.2019000143","volume":"3","author":"S Pagliuca","year":"2019","unstructured":"Pagliuca S, Michonneau D, Sicre de Fontbrune F, Sutra del Galy A, Xhaard A, Robin M, et al. Allogeneic reactivity\u2013mediated endothelial cell complications after HSCT: a plea for consensual definitions. Blood Adv. 2019;3:2424\u201335.","journal-title":"Blood Adv"},{"key":"2506_CR39","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/bmt.2017.39","volume":"52","author":"E Gavriilaki","year":"2017","unstructured":"Gavriilaki E, Sakellari I, Anagnostopoulos A, Brodsky RA. Transplant-associated thrombotic microangiopathy: opening Pandora\u2019s box. Bone Marrow Transplant. 2017;52:1355\u201360. https:\/\/doi.org\/10.1038\/bmt.2017.39.","journal-title":"Bone Marrow Transplant"},{"key":"2506_CR40","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.bbmt.2013.09.005","volume":"19","author":"Y Arai","year":"2013","unstructured":"Arai Y, Yamashita K, Mizugishi K, Watanabe T, Sakamoto S, Kitano T, et al. Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2013;19:1683\u20139. https:\/\/doi.org\/10.1016\/j.bbmt.2013.09.005.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2506_CR41","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.bbmt.2006.11.020","volume":"13","author":"B Oran","year":"2007","unstructured":"Oran B, Donato M, Aleman A, Hosing C, Korbling M, Detry MA, et al. Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment. Biol Blood Marrow Transplant. 2007;13:469\u201377. https:\/\/doi.org\/10.1016\/j.bbmt.2006.11.020.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2506_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S1473-0502(02)00020-4","volume":"27","author":"AS Daly","year":"2002","unstructured":"Daly AS, Hasegawa WS, Lipton JH, Messner HA, Kiss TL. Transplantation-associated thrombotic microangiopathy is associated with transplantation from unrelated donors, acute graft-versus-host disease and venoocclusive disease of the liver. Transfus Apher Sci. 2002;27:3\u201312. https:\/\/doi.org\/10.1016\/S1473-0502(02)00020-4.","journal-title":"Transfus Apher Sci"},{"key":"2506_CR43","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.bbmt.2014.09.028","volume":"21","author":"CE Dandoy","year":"2015","unstructured":"Dandoy CE, Davies SM, Hirsch R, Chima RS, Paff Z, Cash M, et al. Abnormal echocardiography 7 days after stem cell transplantation may be an early indicator of thrombotic microangiopathy. Biol Blood Marrow Transplant. 2015;21:113\u20138. https:\/\/doi.org\/10.1016\/j.bbmt.2014.09.028.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2506_CR44","doi-asserted-by":"publisher","first-page":"83","DOI":"10.21037\/cdt-22-386","volume":"13","author":"DA Liem","year":"2023","unstructured":"Liem DA, Cadeiras M, Setty SP. Insights and perspectives into clinical biomarker discovery in pediatric heart failure and congenital heart disease\u2014a narrative review. Cardiovasc Diagn Ther. 2023;13:83\u201399. https:\/\/doi.org\/10.21037\/cdt-22-386.","journal-title":"Cardiovasc Diagn Ther"},{"key":"2506_CR45","first-page":"38","volume":"67","author":"J Teixeira","year":"2012","unstructured":"Teixeira J, Guillaume M, Nellessen E, Chapelle JP. BNP and NT-proBNP: reference values and cutoff limits [In French]. Rev Med Liege. 2012;67:38\u201343.","journal-title":"Rev Med Liege"},{"key":"2506_CR46","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1161\/CIRCHEARTFAILURE.109.906875","volume":"3","author":"SR Auerbach","year":"2010","unstructured":"Auerbach SR, Richmond ME, Lamour JM, Blume ED, Addonizio LJ, Shaddy RE, et al. BNP levels predict outcome in pediatric heart failure patients: post hoc analysis of the pediatric carvedilol trial. Circ Heart Fail. 2010;3:606\u201311. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.109.906875.","journal-title":"Circ Heart Fail"},{"key":"2506_CR47","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ejhf.1494","volume":"21","author":"C Mueller","year":"2019","unstructured":"Mueller C, McDonald K, de Boer RA, Maisel A, Cleland JGF, Kozhuharov N, et al. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. Eur J Heart Fail. 2019;21:715\u201331. https:\/\/doi.org\/10.1002\/ejhf.1494.","journal-title":"Eur J Heart Fail"},{"key":"2506_CR48","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jtct.2022.11.015","volume":"29","author":"M Schoettler","year":"2023","unstructured":"Schoettler M, Carreras E, Cho B, Dandoy C, Ho V, Jodele S, et al. Harmonizing definitions for diagnostic criteria and prognostic assessment of transplantation-associated thrombotic microangiopathy: a report on behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research. Transplant Cell Ther. 2023;29:151\u201363.","journal-title":"Transplant Cell Ther"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-024-02506-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-024-02506-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-024-02506-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:39:21Z","timestamp":1743813561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-024-02506-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["2506"],"URL":"https:\/\/doi.org\/10.1038\/s41409-024-02506-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4925965\/v1","asserted-by":"object"}]},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"16 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the ethical standards of the Helsinki Declaration and were approved by the Asan Medical Center\u2019s institutional review board (IRB No. 2018-0560). Written informed consent was obtained from all children and patients legal guardians prior to recruitment in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}